PT  - JOURNAL ARTICLE
AU  - Frontera, Jennifer A.
AU  - Yang, Dixon
AU  - Lewis, Ariane
AU  - Patel, Palak
AU  - Medicherla, Chaitanya
AU  - Arena, Vito
AU  - Fang, Taolin
AU  - Andino, Andres
AU  - Snyder, Thomas
AU  - Madhavan, Maya
AU  - Gratch, Daniel
AU  - Fuchs, Benjamin
AU  - Dessy, Alexa
AU  - Canizares, Melanie
AU  - Jauregui, Ruben
AU  - Thomas, Betsy
AU  - Bauman, Kristie
AU  - Olivera, Anlys
AU  - Bhagat, Dhristie
AU  - Sonson, Michael
AU  - Park, George
AU  - Stainman, Rebecca
AU  - Sunwoo, Brian
AU  - Talmasov, Daniel
AU  - Tamimi, Michael
AU  - Zhu, Yingrong
AU  - Rosenthal, Jonathan
AU  - Dygert, Levi
AU  - Ristic, Milan
AU  - Ishii, Haruki
AU  - Valdes, Eduard
AU  - Omari, Mirza
AU  - Gurin, Lindsey
AU  - Huang, Joshua
AU  - Czeisler, Barry M.
AU  - Kahn, D. Ethan
AU  - Zhou, Ting
AU  - Lin, Jessica
AU  - Lord, Aaron S.
AU  - Melmed, Kara
AU  - Meropol, Sharon
AU  - Troxel, Andrea B.
AU  - Petkova, Eva
AU  - Wisniewski, Thomas
AU  - Balcer, Laura
AU  - Morrison, Chris
AU  - Yaghi, Shadi
AU  - Galetta, Steven
TI  - A Prospective Study of Long-Term Outcomes Among Hospitalized COVID-19 Patients with and without Neurological Complications
AID  - 10.1101/2021.03.18.21253881
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.18.21253881
4099  - http://medrxiv.org/content/early/2021/03/20/2021.03.18.21253881.short
4100  - http://medrxiv.org/content/early/2021/03/20/2021.03.18.21253881.full
AB  - Background Little is known regarding long-term outcomes of patients hospitalized with COVID-19.Methods We conducted a prospective study of 6-month outcomes of hospitalized COVID-19 patients. Patients with new neurological complications during hospitalization who survived were propensity score-matched to COVID-19 survivors without neurological complications hospitalized during the same period. The primary 6-month outcome was multivariable ordinal analysis of the modified Rankin Scale(mRS) comparing patients with or without neurological complications. Secondary outcomes included: activities of daily living (ADLs;Barthel Index), telephone Montreal Cognitive Assessment and Neuro-QoL batteries for anxiety, depression, fatigue and sleep.Results Of 606 COVID-19 patients with neurological complications, 395 survived hospitalization and were matched to 395 controls; N=196 neurological patients and N=186 controls completed follow-up. Overall, 346/382 (91%) patients had at least one abnormal outcome: 56% had limited ADLs, 50% impaired cognition, 47% could not return to work and 62% scored worse than average on ≥1 Neuro-QoL scale (worse anxiety 46%, sleep 38%, fatigue 36%, and depression 25%). In multivariable analysis, patients with neurological complications had worse 6-month mRS (median 4 vs. 3 among controls, adjusted OR 2.03, 95%CI 1.22-3.40, P=0.01), worse ADLs (aOR 0.38, 95%CI 0.29-0.74, P=0.01) and were less likely to return to work than controls (41% versus 64%, P=0.04). Cognitive and Neuro-QOL metrics were similar between groups.Conclusions Abnormalities in functional outcomes, ADLs, anxiety, depression and sleep occurred in over 90% of patients 6-months after hospitalization for COVID-19. In multivariable analysis, patients with neurological complications during index hospitalization had significantly worse 6-month functional outcomes than those without.Competing Interest StatementNIH/NIA grant 3P30AG066512-01S1 to Thomas Wisniewski, Jennifer Frontera and Laura Balcer and NIH/NINDS grant 3U24NS11384401S1 to Andrea Troxel, Eva Petkova, Jennifer Frontera, Sharon Meropol and Shadi Yaghi.Funding StatementThis study was funded by NYUAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the NYU Grossman School of Medicine Institutional Review Board. All patients or their surrogates provided consent for participation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data will be made available to qualified investigators upon written request to the corresponding author.